Polyrizon Ltd. has submitted amended claims to expand the scope of its U.S. patent application for its intranasal drug delivery platform. The expanded claims now cover not only the core mucoadhesive composition but also drug delivery systems and methods designed to improve drug effectiveness by increasing residence time and mucosal contact. This move strengthens Polyrizon's global intellectual property portfolio and enhances the potential applicability of its technology across various therapeutic areas. The platform aims to improve drug absorption and efficacy through prolonged retention and controlled film formation on mucosal surfaces.
RootsFi has integrated Cap's stcUSD as a primary yield source on the Tempo payment network, allowing users' balances to earn native yield backed by financial guarantees. This integration combines Tempo's fast Layer 1 payment infrastructure, RootsFi's...
MLCommons announced the MLPerf Training v6.0 benchmark results, introducing two new benchmarks—DeepSeek V3 and GPT-OSS 20B—that highlight the industry's shift toward sparse computation using Mixture-of-Experts (MoE) architectures. These benchmarks te...
AppFolio has enhanced its Performance Platform with new AI-driven features across leasing, accounting, and resident operations, integrating Anthropic’s Claude AI to automate complex workflows. These updates include automated invoice processing, multi...
Metallium Limited has successfully operated three Flash Joule Heating units simultaneously at its Texas facility, marking a key milestone in scaling its proprietary technology. The operation achieved 83% availability and nearly 100% utilization, exce...
Air Comm, a leading provider of wireless communication and security technology, has opened a new office in Farmers Branch, Texas, expanding its presence in the Dallas-Fort Worth area. This new location enhances Air Comm's ability to offer faster loca...
